nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS2—colon cancer	0.696	1	CbGaD
Magnesium salicylate—ALB—Irinotecan—colon cancer	0.0908	0.402	CbGbCtD
Magnesium salicylate—ALB—Fluorouracil—colon cancer	0.0871	0.386	CbGbCtD
Magnesium salicylate—ALB—Methotrexate—colon cancer	0.0481	0.213	CbGbCtD
Magnesium salicylate—ALB—gall bladder—colon cancer	0.00277	0.122	CbGeAlD
Magnesium salicylate—Localized exfoliation—Capecitabine—colon cancer	0.00253	0.053	CcSEcCtD
Magnesium salicylate—PTGS1—endothelium—colon cancer	0.00182	0.0801	CbGeAlD
Magnesium salicylate—PTGS2—endothelium—colon cancer	0.00174	0.0766	CbGeAlD
Magnesium salicylate—PTGS1—blood vessel—colon cancer	0.00168	0.0739	CbGeAlD
Magnesium salicylate—Trisalicylate-choline—PTGS2—colon cancer	0.00167	0.222	CrCbGaD
Magnesium salicylate—Olsalazine—PPARG—colon cancer	0.00164	0.219	CrCbGaD
Magnesium salicylate—PTGS2—blood vessel—colon cancer	0.0016	0.0706	CbGeAlD
Magnesium salicylate—PTGS2—gall bladder—colon cancer	0.00151	0.0665	CbGeAlD
Magnesium salicylate—Heartburn—Fluorouracil—colon cancer	0.00142	0.0297	CcSEcCtD
Magnesium salicylate—Stinging—Fluorouracil—colon cancer	0.0012	0.0252	CcSEcCtD
Magnesium salicylate—Gastric ulcer—Capecitabine—colon cancer	0.00117	0.0246	CcSEcCtD
Magnesium salicylate—Salicylate-sodium—PTGS2—colon cancer	0.00101	0.135	CrCbGaD
Magnesium salicylate—PTGS2—embryo—colon cancer	0.000956	0.0421	CbGeAlD
Magnesium salicylate—Oesophagitis—Fluorouracil—colon cancer	0.000891	0.0187	CcSEcCtD
Magnesium salicylate—Deafness—Vincristine—colon cancer	0.000848	0.0178	CcSEcCtD
Magnesium salicylate—PTGS1—epithelium—colon cancer	0.000816	0.036	CbGeAlD
Magnesium salicylate—ALB—liver—colon cancer	0.000811	0.0358	CbGeAlD
Magnesium salicylate—PTGS1—smooth muscle tissue—colon cancer	0.000786	0.0347	CbGeAlD
Magnesium salicylate—PTGS2—epithelium—colon cancer	0.00078	0.0344	CbGeAlD
Magnesium salicylate—PTGS1—renal system—colon cancer	0.000757	0.0334	CbGeAlD
Magnesium salicylate—PTGS2—smooth muscle tissue—colon cancer	0.000751	0.0331	CbGeAlD
Magnesium salicylate—Hypocalcaemia—Capecitabine—colon cancer	0.000744	0.0156	CcSEcCtD
Magnesium salicylate—Burning sensation—Methotrexate—colon cancer	0.00073	0.0153	CcSEcCtD
Magnesium salicylate—PTGS2—renal system—colon cancer	0.000723	0.0319	CbGeAlD
Magnesium salicylate—Lethargy—Fluorouracil—colon cancer	0.000722	0.0151	CcSEcCtD
Magnesium salicylate—Hearing impaired—Capecitabine—colon cancer	0.000716	0.015	CcSEcCtD
Magnesium salicylate—Nepafenac—PTGS2—colon cancer	0.00071	0.0944	CrCbGaD
Magnesium salicylate—Olsalazine—PTGS2—colon cancer	0.000694	0.0923	CrCbGaD
Magnesium salicylate—Stupor—Methotrexate—colon cancer	0.000679	0.0142	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Capecitabine—colon cancer	0.000658	0.0138	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Capecitabine—colon cancer	0.000651	0.0136	CcSEcCtD
Magnesium salicylate—Oesophagitis—Capecitabine—colon cancer	0.000623	0.013	CcSEcCtD
Magnesium salicylate—ALB—lymph node—colon cancer	0.000622	0.0274	CbGeAlD
Magnesium salicylate—PTGS1—digestive system—colon cancer	0.000621	0.0274	CbGeAlD
Magnesium salicylate—Ecchymosis—Capecitabine—colon cancer	0.000616	0.0129	CcSEcCtD
Magnesium salicylate—PTGS2—lymphoid tissue—colon cancer	0.000601	0.0265	CbGeAlD
Magnesium salicylate—PTGS2—digestive system—colon cancer	0.000593	0.0262	CbGeAlD
Magnesium salicylate—Salsalate—PTGS2—colon cancer	0.00059	0.0785	CrCbGaD
Magnesium salicylate—Sweating—Vincristine—colon cancer	0.000561	0.0117	CcSEcCtD
Magnesium salicylate—Deafness—Capecitabine—colon cancer	0.000553	0.0116	CcSEcCtD
Magnesium salicylate—PTGS1—vagina—colon cancer	0.000548	0.0242	CbGeAlD
Magnesium salicylate—PTGS2—bone marrow—colon cancer	0.000547	0.0241	CbGeAlD
Magnesium salicylate—Sweating—Irinotecan—colon cancer	0.000546	0.0114	CcSEcCtD
Magnesium salicylate—PTGS2—vagina—colon cancer	0.000524	0.0231	CbGeAlD
Magnesium salicylate—Hallucination—Vincristine—colon cancer	0.000522	0.0109	CcSEcCtD
Magnesium salicylate—Epistaxis—Fluorouracil—colon cancer	0.000514	0.0108	CcSEcCtD
Magnesium salicylate—Lethargy—Capecitabine—colon cancer	0.000505	0.0106	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Methotrexate—colon cancer	0.00049	0.0103	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Methotrexate—colon cancer	0.000484	0.0101	CcSEcCtD
Magnesium salicylate—Flushing—Irinotecan—colon cancer	0.000474	0.00994	CcSEcCtD
Magnesium salicylate—Ecchymosis—Methotrexate—colon cancer	0.000459	0.0096	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Capecitabine—colon cancer	0.000452	0.00946	CcSEcCtD
Magnesium salicylate—PTGS2—liver—colon cancer	0.000442	0.0195	CbGeAlD
Magnesium salicylate—Asthma—Capecitabine—colon cancer	0.000427	0.00895	CcSEcCtD
Magnesium salicylate—Erythema—Fluorouracil—colon cancer	0.000426	0.00893	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Capecitabine—colon cancer	0.00041	0.00858	CcSEcCtD
Magnesium salicylate—Weight increased—Capecitabine—colon cancer	0.000389	0.00815	CcSEcCtD
Magnesium salicylate—Lethargy—Methotrexate—colon cancer	0.000376	0.00787	CcSEcCtD
Magnesium salicylate—Oedema—Vincristine—colon cancer	0.000373	0.00781	CcSEcCtD
Magnesium salicylate—Confusional state—Irinotecan—colon cancer	0.000366	0.00767	CcSEcCtD
Magnesium salicylate—Oedema—Irinotecan—colon cancer	0.000363	0.00761	CcSEcCtD
Magnesium salicylate—Salicylic acid—PTGS2—colon cancer	0.000363	0.0483	CrCbGaD
Magnesium salicylate—Hyperhidrosis—Vincristine—colon cancer	0.000361	0.00755	CcSEcCtD
Magnesium salicylate—Epistaxis—Capecitabine—colon cancer	0.00036	0.00753	CcSEcCtD
Magnesium salicylate—Shock—Irinotecan—colon cancer	0.000357	0.00748	CcSEcCtD
Magnesium salicylate—Anorexia—Vincristine—colon cancer	0.000356	0.00744	CcSEcCtD
Magnesium salicylate—PTGS1—lymph node—colon cancer	0.000355	0.0156	CbGeAlD
Magnesium salicylate—Hyperhidrosis—Irinotecan—colon cancer	0.000351	0.00735	CcSEcCtD
Magnesium salicylate—Confusional state—Fluorouracil—colon cancer	0.000351	0.00735	CcSEcCtD
Magnesium salicylate—Hypotension—Vincristine—colon cancer	0.000349	0.0073	CcSEcCtD
Magnesium salicylate—Oedema—Fluorouracil—colon cancer	0.000348	0.00728	CcSEcCtD
Magnesium salicylate—Anorexia—Irinotecan—colon cancer	0.000346	0.00725	CcSEcCtD
Magnesium salicylate—Hepatitis—Capecitabine—colon cancer	0.000342	0.00717	CcSEcCtD
Magnesium salicylate—Hypotension—Irinotecan—colon cancer	0.000339	0.00711	CcSEcCtD
Magnesium salicylate—PTGS2—lymph node—colon cancer	0.000339	0.0149	CbGeAlD
Magnesium salicylate—Anorexia—Fluorouracil—colon cancer	0.000332	0.00694	CcSEcCtD
Magnesium salicylate—Hypotension—Fluorouracil—colon cancer	0.000325	0.00681	CcSEcCtD
Magnesium salicylate—Decreased appetite—Vincristine—colon cancer	0.000324	0.00679	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Capecitabine—colon cancer	0.000324	0.00677	CcSEcCtD
Magnesium salicylate—Somnolence—Irinotecan—colon cancer	0.000323	0.00676	CcSEcCtD
Magnesium salicylate—Dyspepsia—Irinotecan—colon cancer	0.00032	0.0067	CcSEcCtD
Magnesium salicylate—Tinnitus—Capecitabine—colon cancer	0.000319	0.00668	CcSEcCtD
Magnesium salicylate—Constipation—Vincristine—colon cancer	0.000319	0.00668	CcSEcCtD
Magnesium salicylate—Pain—Vincristine—colon cancer	0.000319	0.00668	CcSEcCtD
Magnesium salicylate—Asthma—Methotrexate—colon cancer	0.000318	0.00666	CcSEcCtD
Magnesium salicylate—Flushing—Capecitabine—colon cancer	0.000318	0.00665	CcSEcCtD
Magnesium salicylate—Decreased appetite—Irinotecan—colon cancer	0.000316	0.00661	CcSEcCtD
Magnesium salicylate—Pain—Irinotecan—colon cancer	0.000311	0.0065	CcSEcCtD
Magnesium salicylate—Constipation—Irinotecan—colon cancer	0.000311	0.0065	CcSEcCtD
Magnesium salicylate—Somnolence—Fluorouracil—colon cancer	0.000309	0.00648	CcSEcCtD
Magnesium salicylate—Salicylic acid—ABCB1—colon cancer	0.000309	0.041	CrCbGaD
Magnesium salicylate—Dyspepsia—Fluorouracil—colon cancer	0.000306	0.00641	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Methotrexate—colon cancer	0.000305	0.00639	CcSEcCtD
Magnesium salicylate—Decreased appetite—Fluorouracil—colon cancer	0.000302	0.00633	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Irinotecan—colon cancer	0.000299	0.00627	CcSEcCtD
Magnesium salicylate—Erythema—Capecitabine—colon cancer	0.000298	0.00624	CcSEcCtD
Magnesium salicylate—Pain—Fluorouracil—colon cancer	0.000297	0.00623	CcSEcCtD
Magnesium salicylate—Dysgeusia—Capecitabine—colon cancer	0.000292	0.00611	CcSEcCtD
Magnesium salicylate—Ketoprofen—PTGS2—colon cancer	0.000288	0.0383	CrCbGaD
Magnesium salicylate—Feeling abnormal—Fluorouracil—colon cancer	0.000287	0.006	CcSEcCtD
Magnesium salicylate—Drowsiness—Methotrexate—colon cancer	0.000284	0.00594	CcSEcCtD
Magnesium salicylate—Urticaria—Fluorouracil—colon cancer	0.000276	0.00579	CcSEcCtD
Magnesium salicylate—Sweating—Methotrexate—colon cancer	0.000272	0.0057	CcSEcCtD
Magnesium salicylate—Epistaxis—Methotrexate—colon cancer	0.000268	0.0056	CcSEcCtD
Magnesium salicylate—Diarrhoea—Vincristine—colon cancer	0.000255	0.00534	CcSEcCtD
Magnesium salicylate—Hepatitis—Methotrexate—colon cancer	0.000255	0.00533	CcSEcCtD
Magnesium salicylate—Diarrhoea—Irinotecan—colon cancer	0.000249	0.0052	CcSEcCtD
Magnesium salicylate—Dizziness—Vincristine—colon cancer	0.000247	0.00516	CcSEcCtD
Magnesium salicylate—Pruritus—Fluorouracil—colon cancer	0.000246	0.00515	CcSEcCtD
Magnesium salicylate—Confusional state—Capecitabine—colon cancer	0.000245	0.00513	CcSEcCtD
Magnesium salicylate—Oedema—Capecitabine—colon cancer	0.000243	0.00509	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Methotrexate—colon cancer	0.000241	0.00504	CcSEcCtD
Magnesium salicylate—Dizziness—Irinotecan—colon cancer	0.00024	0.00503	CcSEcCtD
Magnesium salicylate—Shock—Capecitabine—colon cancer	0.000239	0.00501	CcSEcCtD
Magnesium salicylate—Diarrhoea—Fluorouracil—colon cancer	0.000238	0.00498	CcSEcCtD
Magnesium salicylate—Tinnitus—Methotrexate—colon cancer	0.000237	0.00497	CcSEcCtD
Magnesium salicylate—Carbamazepine—ABCB1—colon cancer	0.000237	0.0315	CrCbGaD
Magnesium salicylate—Vomiting—Vincristine—colon cancer	0.000237	0.00497	CcSEcCtD
Magnesium salicylate—Rash—Vincristine—colon cancer	0.000235	0.00492	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Capecitabine—colon cancer	0.000235	0.00492	CcSEcCtD
Magnesium salicylate—Dermatitis—Vincristine—colon cancer	0.000235	0.00492	CcSEcCtD
Magnesium salicylate—Headache—Vincristine—colon cancer	0.000234	0.00489	CcSEcCtD
Magnesium salicylate—Anorexia—Capecitabine—colon cancer	0.000232	0.00485	CcSEcCtD
Magnesium salicylate—Vomiting—Irinotecan—colon cancer	0.000231	0.00484	CcSEcCtD
Magnesium salicylate—Dizziness—Fluorouracil—colon cancer	0.00023	0.00482	CcSEcCtD
Magnesium salicylate—Rash—Irinotecan—colon cancer	0.000229	0.0048	CcSEcCtD
Magnesium salicylate—Dermatitis—Irinotecan—colon cancer	0.000229	0.00479	CcSEcCtD
Magnesium salicylate—Headache—Irinotecan—colon cancer	0.000228	0.00477	CcSEcCtD
Magnesium salicylate—Hypotension—Capecitabine—colon cancer	0.000227	0.00476	CcSEcCtD
Magnesium salicylate—Erythema—Methotrexate—colon cancer	0.000222	0.00464	CcSEcCtD
Magnesium salicylate—Nausea—Vincristine—colon cancer	0.000222	0.00464	CcSEcCtD
Magnesium salicylate—Vomiting—Fluorouracil—colon cancer	0.000221	0.00463	CcSEcCtD
Magnesium salicylate—Rash—Fluorouracil—colon cancer	0.000219	0.00459	CcSEcCtD
Magnesium salicylate—Dermatitis—Fluorouracil—colon cancer	0.000219	0.00459	CcSEcCtD
Magnesium salicylate—Headache—Fluorouracil—colon cancer	0.000218	0.00456	CcSEcCtD
Magnesium salicylate—Dysgeusia—Methotrexate—colon cancer	0.000217	0.00455	CcSEcCtD
Magnesium salicylate—Nausea—Irinotecan—colon cancer	0.000216	0.00452	CcSEcCtD
Magnesium salicylate—Dyspepsia—Capecitabine—colon cancer	0.000214	0.00448	CcSEcCtD
Magnesium salicylate—Decreased appetite—Capecitabine—colon cancer	0.000211	0.00443	CcSEcCtD
Magnesium salicylate—Pain—Capecitabine—colon cancer	0.000208	0.00435	CcSEcCtD
Magnesium salicylate—Constipation—Capecitabine—colon cancer	0.000208	0.00435	CcSEcCtD
Magnesium salicylate—Nausea—Fluorouracil—colon cancer	0.000207	0.00433	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Capecitabine—colon cancer	0.0002	0.0042	CcSEcCtD
Magnesium salicylate—Urticaria—Capecitabine—colon cancer	0.000193	0.00404	CcSEcCtD
Magnesium salicylate—Confusional state—Methotrexate—colon cancer	0.000182	0.00382	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Methotrexate—colon cancer	0.000175	0.00366	CcSEcCtD
Magnesium salicylate—Anorexia—Methotrexate—colon cancer	0.000172	0.00361	CcSEcCtD
Magnesium salicylate—Pruritus—Capecitabine—colon cancer	0.000172	0.0036	CcSEcCtD
Magnesium salicylate—Hypotension—Methotrexate—colon cancer	0.000169	0.00354	CcSEcCtD
Magnesium salicylate—Diarrhoea—Capecitabine—colon cancer	0.000166	0.00348	CcSEcCtD
Magnesium salicylate—Somnolence—Methotrexate—colon cancer	0.000161	0.00337	CcSEcCtD
Magnesium salicylate—Dizziness—Capecitabine—colon cancer	0.000161	0.00337	CcSEcCtD
Magnesium salicylate—Dyspepsia—Methotrexate—colon cancer	0.000159	0.00334	CcSEcCtD
Magnesium salicylate—Decreased appetite—Methotrexate—colon cancer	0.000157	0.00329	CcSEcCtD
Magnesium salicylate—Pain—Methotrexate—colon cancer	0.000155	0.00324	CcSEcCtD
Magnesium salicylate—Vomiting—Capecitabine—colon cancer	0.000155	0.00324	CcSEcCtD
Magnesium salicylate—Rash—Capecitabine—colon cancer	0.000153	0.00321	CcSEcCtD
Magnesium salicylate—Dermatitis—Capecitabine—colon cancer	0.000153	0.00321	CcSEcCtD
Magnesium salicylate—Headache—Capecitabine—colon cancer	0.000152	0.00319	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Methotrexate—colon cancer	0.000149	0.00312	CcSEcCtD
Magnesium salicylate—Nausea—Capecitabine—colon cancer	0.000144	0.00302	CcSEcCtD
Magnesium salicylate—Urticaria—Methotrexate—colon cancer	0.000144	0.00301	CcSEcCtD
Magnesium salicylate—Pruritus—Methotrexate—colon cancer	0.000128	0.00268	CcSEcCtD
Magnesium salicylate—Diarrhoea—Methotrexate—colon cancer	0.000124	0.00259	CcSEcCtD
Magnesium salicylate—Dizziness—Methotrexate—colon cancer	0.00012	0.00251	CcSEcCtD
Magnesium salicylate—Vomiting—Methotrexate—colon cancer	0.000115	0.00241	CcSEcCtD
Magnesium salicylate—Rash—Methotrexate—colon cancer	0.000114	0.00239	CcSEcCtD
Magnesium salicylate—Dermatitis—Methotrexate—colon cancer	0.000114	0.00239	CcSEcCtD
Magnesium salicylate—Headache—Methotrexate—colon cancer	0.000113	0.00237	CcSEcCtD
Magnesium salicylate—Nausea—Methotrexate—colon cancer	0.000107	0.00225	CcSEcCtD
